{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T01:43:45Z","timestamp":1790905425530,"version":"4.1.0"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T00:00:00Z","timestamp":1758153600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Cardiovasc Imaging"],"DOI":"10.1007\/s10554-025-03518-3","type":"journal-article","created":{"date-parts":[[2025,9,18]],"date-time":"2025-09-18T02:44:00Z","timestamp":1758163440000},"page":"2149-2158","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["The influence of genotype on the phenotype and prognosis of patients with hypertrophic cardiomyopathy"],"prefix":"10.1007","volume":"41","author":[{"given":"In\u00eas Macedo","family":"Conde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana","family":"Gr\u00e1cio Machado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catarina","family":"Vieira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitor Hugo","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,18]]},"reference":[{"issue":"7","key":"3518_CR1","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/CIRCRESAHA.117.311059","volume":"121","author":"AJ Marian","year":"2017","unstructured":"Marian AJ, Braunwald E (2017) Hypertrophic cardiomyopathy: genetics, pathogenesis, clinical manifestations, diagnosis, and therapy. Circ Res 121(7):749\u2013770. https:\/\/doi.org\/10.1161\/CIRCRESAHA.117.311059","journal-title":"Circ Res"},{"issue":"2","key":"3518_CR2","doi-asserted-by":"publisher","first-page":"80","DOI":"10.15420\/ecr.2017:12:1","volume":"12","author":"A Malhotra","year":"2017","unstructured":"Malhotra A, Sharma S (2017) Hypertrophic cardiomyopathy in athletes. Eur Cardiol 12(2):80\u201382. https:\/\/doi.org\/10.15420\/ecr.2017:12:1","journal-title":"Eur Cardiol"},{"issue":"37","key":"3518_CR3","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo E, Protonotarios A, Gimeno JR, ESC Scientific Document Group et al (2023) 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart J 44(37):3503\u20133626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194","journal-title":"Eur Heart J"},{"issue":"5","key":"3518_CR4","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/0092-8674(90)90274-i","volume":"62","author":"AA Geisterfer-Lowrance","year":"1990","unstructured":"Geisterfer-Lowrance AA, Kass S, Tanigawa G et al (1990) A molecular basis for Familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell 62(5):999\u20131006. https:\/\/doi.org\/10.1016\/0092-8674(90)90274-i","journal-title":"Cell"},{"issue":"3","key":"3518_CR5","doi-asserted-by":"publisher","first-page":"682","DOI":"10.3390\/biomedicines12030682","volume":"12","author":"MT Abbas","year":"2024","unstructured":"Abbas MT, Baba Ali N, Farina JM et al (2024) Role of genetics in diagnosis and management of hypertrophic cardiomyopathy: a glimpse into the future. Biomedicines 12(3):682. https:\/\/doi.org\/10.3390\/biomedicines12030682","journal-title":"Biomedicines"},{"issue":"2","key":"3518_CR6","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s12265-016-9681-5","volume":"9","author":"SL Murphy","year":"2016","unstructured":"Murphy SL, Anderson JH, Kapplinger JD et al (2016) Evaluation of the Mayo Clinic phenotype-based genotype predictor score in patients with clinically diagnosed hypertrophic cardiomyopathy. J Cardiovasc Transl Res 9(2):153\u2013161. https:\/\/doi.org\/10.1007\/s12265-016-9681-5","journal-title":"J Cardiovasc Transl Res"},{"issue":"10","key":"3518_CR7","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.033565","volume":"13","author":"J Bonaventura","year":"2024","unstructured":"Bonaventura J, Rowin EJ, Chan RH et al (2024) Relationship between genotype status and clinical outcome in hypertrophic cardiomyopathy. J Am Heart Assoc 13(10):e033565. https:\/\/doi.org\/10.1161\/JAHA.123.033565","journal-title":"J Am Heart Assoc"},{"key":"3518_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/ehf2.14848","author":"T Saul","year":"2024","unstructured":"Saul T, Bui QM, Argiro A et al (2024) Natural history and clinical outcomes of patients with hypertrophic cardiomyopathy from thin filament mutations. ESC heart failure. https:\/\/doi.org\/10.1002\/ehf2.14848","journal-title":"ESC heart failure"},{"issue":"24","key":"3518_CR9","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1016\/j.jacc.2014.09.059","volume":"64","author":"R Coppini","year":"2014","unstructured":"Coppini R, Ho CY, Ashley E et al (2014) Clinical phenotype and outcome of hypertrophic cardiomyopathy associated with thin-filament gene mutations. J Am Coll Cardiol 64(24):2589\u20132600. https:\/\/doi.org\/10.1016\/j.jacc.2014.09.059","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"3518_CR10","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1016\/j.jacc.2004.04.039","volume":"44","author":"SL Van Driest","year":"2004","unstructured":"Van Driest SL, Jaeger MA, Ommen SR et al (2004) Comprehensive analysis of the beta-myosin heavy chain gene in 389 unrelated patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 44(3):602\u2013610. https:\/\/doi.org\/10.1016\/j.jacc.2004.04.039","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"3518_CR11","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1186\/s12872-020-01807-4","volume":"20","author":"L Velicki","year":"2020","unstructured":"Velicki L, Jakovljevic DG, Preveden A et al (2020) Genetic determinants of clinical phenotype in hypertrophic cardiomyopathy. BMC Cardiovasc Disord 20(1):516. https:\/\/doi.org\/10.1186\/s12872-020-01807-4","journal-title":"BMC Cardiovasc Disord"},{"issue":"11","key":"3518_CR12","doi-asserted-by":"publisher","first-page":"e0187948","DOI":"10.1371\/journal.pone.0187948","volume":"12","author":"SK Viswanathan","year":"2017","unstructured":"Viswanathan SK, Sanders HK, McNamara JW et al (2017) Hypertrophic cardiomyopathy clinical phenotype is independent of gene mutation and mutation dosage. PLoS ONE 12(11):e0187948. https:\/\/doi.org\/10.1371\/journal.pone.0187948","journal-title":"PLoS ONE"},{"issue":"1","key":"3518_CR13","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/S0300-8932(09)70020-X","volume":"62","author":"M Garc\u00eda-Castro","year":"2009","unstructured":"Garc\u00eda-Castro M, Coto E, Reguero JR et al (2009) Mutations in sarcomeric genes MYH7, MYBPC3, TNNT2, TNNI3, and TPM1 in patients with hypertrophic cardiomyopathy. Revista Espa\u00f1ola De Cardiologia 62(1):48\u201356. https:\/\/doi.org\/10.1016\/S0300-8932(09)70020-X","journal-title":"Revista Espa\u00f1ola De Cardiologia"},{"issue":"1","key":"3518_CR14","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1161\/01.cir.103.1.65","volume":"103","author":"A Karibe","year":"2001","unstructured":"Karibe A, Tobacman LS, Strand J et al (2001) Hypertrophic cardiomyopathy caused by a novel alpha-tropomyosin mutation (V95A) is associated with mild cardiac phenotype, abnormal calcium binding to troponin, abnormal myosin cycling, and poor prognosis. Circulation 103(1):65\u201371. https:\/\/doi.org\/10.1161\/01.cir.103.1.65","journal-title":"Circulation"},{"issue":"40","key":"3518_CR15","doi-asserted-by":"publisher","first-page":"e27445","DOI":"10.1097\/MD.0000000000027445","volume":"100","author":"Z Chen","year":"2021","unstructured":"Chen Z, Xu B (2021) Clinical significance of overweight in patients with hypertrophic cardiomyopathy: a retrospective cohort study. Medicine 100(40):e27445. https:\/\/doi.org\/10.1097\/MD.0000000000027445","journal-title":"Medicine"},{"issue":"9","key":"3518_CR16","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1016\/j.repc.2011.12.020","volume":"31","author":"D Brito","year":"2012","unstructured":"Brito D, Miltenberger-Miltenyi G, Vale Pereira S et al (2012) Sarcomeric hypertrophic cardiomyopathy: genetic profile in a Portuguese population. Rev Port Cardiol 31(9):577\u2013587. https:\/\/doi.org\/10.1016\/j.repc.2011.12.020","journal-title":"Rev Port Cardiol"},{"issue":"30","key":"3518_CR17","doi-asserted-by":"publisher","first-page":"2727","DOI":"10.1093\/eurheartj\/ehae421","volume":"45","author":"LR Lopes","year":"2024","unstructured":"Lopes LR, Ho CY, Elliott PM (2024) Genetics of hypertrophic cardiomyopathy: established and emerging implications for clinical practice. Eur Heart J 45(30):2727\u20132734. https:\/\/doi.org\/10.1093\/eurheartj\/ehae421","journal-title":"Eur Heart J"},{"key":"3518_CR18","doi-asserted-by":"publisher","unstructured":"Borrelli F, Losi MA, Canciello G et al (2023) Sarcomeric versus non-sarcomeric HCM. Cardiogenetics 2023, 13(2), 92\u2013105. https:\/\/doi.org\/10.3390\/cardiogenetics13020009","DOI":"10.3390\/cardiogenetics13020009"},{"issue":"2","key":"3518_CR19","doi-asserted-by":"publisher","first-page":"120","DOI":"10.2463\/mrms.rev.2017-0145","volume":"17","author":"Y Amano","year":"2018","unstructured":"Amano Y, Kitamura M, Takano H et al (2018) Cardiac MR imaging of hypertrophic cardiomyopathy: techniques, findings, and clinical relevance. Magn Reson Med Sci 17(2):120\u2013131. https:\/\/doi.org\/10.2463\/mrms.rev.2017-0145","journal-title":"Magn Reson Med Sci"},{"key":"3518_CR20","doi-asserted-by":"publisher","unstructured":"Batzner A, Sch\u00e4fers HJ, Borisov KV et al (2019) Hypertrophic obstructive cardiomyopathy. Deutsches Arzteblatt international 2019;116(4):47\u201353. https:\/\/doi.org\/10.3238\/arztebl.2019.0047","DOI":"10.3238\/arztebl.2019.0047"},{"issue":"1","key":"3518_CR21","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1111\/j.1445-5994.1997.tb00914.x","volume":"27","author":"C Semsarian","year":"1997","unstructured":"Semsarian C, French J, Trent RJ et al (1997) The natural history of left ventricular wall thickening in hypertrophic cardiomyopathy. Aust N Z J Med 27(1):51\u201358. https:\/\/doi.org\/10.1111\/j.1445-5994.1997.tb00914.x","journal-title":"Aust N Z J Med"},{"issue":"6","key":"3518_CR22","doi-asserted-by":"publisher","first-page":"e17336","DOI":"10.1016\/j.heliyon.2023.e17336","volume":"9","author":"D Tore","year":"2023","unstructured":"Tore D, Faletti R, Gaetani C et al (2023) Cardiac magnetic resonance of hypertrophic heart phenotype: a review. Heliyon 9(6):e17336. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17336","journal-title":"Heliyon"},{"issue":"11","key":"3518_CR23","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1016\/j.jacc.2010.05.010","volume":"56","author":"R O\u2019Hanlon","year":"2010","unstructured":"O\u2019Hanlon R, Grasso A, Roughton M et al (2010) Prognostic significance of myocardial fibrosis in hypertrophic cardiomyopathy. J Am Coll Cardiol 56(11):867\u2013874. https:\/\/doi.org\/10.1016\/j.jacc.2010.05.010","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"3518_CR24","doi-asserted-by":"publisher","first-page":"e17629","DOI":"10.1016\/j.heliyon.2023.e17629","volume":"9","author":"Y He","year":"2023","unstructured":"He Y, Yu C, Zhou L et al (2023) Prognosis of patients with familial hypertrophic cardiomyopathy: a single-center cohort study with ten-year follow-up by propensity score matching analysis. Heliyon 9(7):e17629. https:\/\/doi.org\/10.1016\/j.heliyon.2023.e17629","journal-title":"Heliyon"},{"issue":"6","key":"3518_CR25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCGEN.123.004200","volume":"16","author":"L Curran","year":"2023","unstructured":"Curran L, de Marvao A, Inglese P et al (2023) Genotype-phenotype taxonomy of hypertrophic cardiomyopathy. Circ Genom Precis Med 16(6):e004200. https:\/\/doi.org\/10.1161\/CIRCGEN.123.004200","journal-title":"Circ Genom Precis Med"},{"issue":"2","key":"3518_CR26","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCIMAGING.117.006066","volume":"10","author":"A Tower-Rader","year":"2017","unstructured":"Tower-Rader A, Desai MY (2017) Phenotype-genotype correlation in hypertrophic cardiomyopathy: less signal, more noise?? Circ Cardiovasc Imaging 10(2):e006066. https:\/\/doi.org\/10.1161\/CIRCIMAGING.117.006066","journal-title":"Circ Cardiovasc Imaging"},{"issue":"Supplement_1","key":"3518_CR27","doi-asserted-by":"publisher","DOI":"10.1093\/europace\/euae102.641","volume":"26","author":"SH Kim","year":"2024","unstructured":"Kim SH, Jeong JH, Kim HJ et al (2024) Clinical features and prognosis according to genotype variation in hypertrophic cardiomyopathy. Europace 26(Supplement_1):euae102.641. https:\/\/doi.org\/10.1093\/europace\/euae102.641","journal-title":"Europace"},{"issue":"6\u20137","key":"3518_CR28","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.acvd.2023.04.008","volume":"116","author":"C Wanert","year":"2023","unstructured":"Wanert C, El Louali F, Al Dybiat S et al (2023) Genetic profile and genotype-phenotype correlations in childhood cardiomyopathy. Arch Cardiovasc Dis 116(6\u20137):309\u2013315. https:\/\/doi.org\/10.1016\/j.acvd.2023.04.008","journal-title":"Arch Cardiovasc Dis"},{"issue":"4","key":"3518_CR29","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1093\/ehjci\/jet234","volume":"15","author":"JB Geske","year":"2014","unstructured":"Geske JB, Bos JM, Gersh BJ et al (2014) Deformation patterns in genotyped patients with hypertrophic cardiomyopathy. Eur Heart J 15(4):456\u2013465. https:\/\/doi.org\/10.1093\/ehjci\/jet234","journal-title":"Eur Heart J"},{"key":"3518_CR30","doi-asserted-by":"publisher","unstructured":"Gwak SY, Seo J, Seo GH et al (2024) Role of genetic testing in diagnosis and prognosis prediction in hypertrophic cardiomyopathy in Korea. J Korean Med Sci. 2024;39(50):e313. https:\/\/doi.org\/10.3346\/jkms.2024.39.e313","DOI":"10.3346\/jkms.2024.39.e313"},{"issue":"3","key":"3518_CR31","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/clc.20151","volume":"31","author":"S Wang","year":"2008","unstructured":"Wang S, Zou Y, Fu C et al (2008) Worse prognosis with gene mutations of beta-myosin heavy chain than myosin-binding protein C in Chinese patients with hypertrophic cardiomyopathy. Clin Cardiol 31(3):114\u2013118. https:\/\/doi.org\/10.1002\/clc.20151","journal-title":"Clin Cardiol"},{"key":"3518_CR32","doi-asserted-by":"publisher","unstructured":"Boen HM, Alaerts M, Van Laer L et al (2024) Phenotypic spectrum of the first Belgian MYBPC3 founder: A large multi-exon deletion with a varying phenotype. Front. Genet., 21 May 2024. https:\/\/doi.org\/10.3389\/fgene.2024.1392527","DOI":"10.3389\/fgene.2024.1392527"},{"issue":"3","key":"3518_CR33","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/ccr3.832","volume":"5","author":"EA Clemente","year":"2017","unstructured":"Clemente EA, Casas A, Lasheras CG et al (2017) Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3. Clin Case Rep 5(3):232\u2013237. https:\/\/doi.org\/10.1002\/ccr3.832","journal-title":"Clin Case Rep"},{"issue":"22","key":"3518_CR34","doi-asserted-by":"publisher","first-page":"2230","DOI":"10.1161\/01.cir.97.22.2230","volume":"97","author":"P Charron","year":"1998","unstructured":"Charron P, Dubourg O, Desnos M et al (1998) Clinical features and prognostic implications of familial hypertrophic cardiomyopathy related to the cardiac myosin-binding protein C gene. Circulation 97(22):2230\u20132236. https:\/\/doi.org\/10.1161\/01.cir.97.22.2230","journal-title":"Circulation"},{"issue":"13","key":"3518_CR35","doi-asserted-by":"publisher","DOI":"10.3390\/ijms241310510","volume":"24","author":"BS Tudurachi","year":"2023","unstructured":"Tudurachi BS, Z\u0103voi A, Leonte A et al (2023) An update on MYBPC3 gene mutation in hypertrophic cardiomyopathy. Int J Mol Sci 24(13):10510. https:\/\/doi.org\/10.3390\/ijms241310510","journal-title":"Int J Mol Sci"},{"issue":"9","key":"3518_CR36","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1253\/circj.CJ-19-0190","volume":"83","author":"MT Tran Vu","year":"2019","unstructured":"Tran Vu MT, Nguyen TV, Huynh NV et al (2019) Presence of hypertrophic cardiomyopathy related gene mutations and clinical manifestations in Vietnamese patients with hypertrophic cardiomyopathy. Circulation Journa 83(9):1908\u20131916. https:\/\/doi.org\/10.1253\/circj.CJ-19-0190","journal-title":"Circulation Journa"},{"key":"3518_CR37","doi-asserted-by":"crossref","unstructured":"Lamounier Junior A, Gonz\u00e1lez A, Vilela A et al (2022) Genotype-phenotype correlations in hypertrophic cardiomyopathy A multicenter study in Portugal and Spain of the TPM1 p.Arg21Leuvariant Revista espanola de cardiologia, 75(3), 242\u2013250.","DOI":"10.1016\/j.rec.2021.01.001"}],"container-title":["The International Journal of Cardiovascular Imaging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10554-025-03518-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10554-025-03518-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T22:05:52Z","timestamp":1763417152000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10554-025-03518-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,18]]},"references-count":37,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025,11]]}},"alternative-id":["3518"],"URL":"https:\/\/doi.org\/10.1007\/s10554-025-03518-3","relation":{},"ISSN":["1875-8312"],"issn-type":[{"value":"1875-8312","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,18]]},"assertion":[{"value":"2 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}